Clinical features, serological findings, and survival rate comparison between early versus late-onset systemic lupus erythematosus from 2000 to 2010, two centers experience
Abstract
Objective: The study aimed to compare the differences in patients diagnosed with early versus late-onset systemic lupus erythematosus (SLE) in terms of clinical features, disease activity, laboratory findings, and the 5-year survival rate.
Materials and Methods: All newly diagnosed SLE patients from 2000 to 2010 in two tertiary centers in Saudi Arabia were enrolled. Retrospectively, early-onset SLE (18–49 years at the age of diagnosis) was compared to late-onset SLE (≥50 years at the age of diagnosis) using chart review of their clinical features, serology, and organ damage and disease activity.
Results: A 196 SLE patients were included, 156 were in the early-onset SLE group while 40 in the late-onset SLE group. Arthritis was a frequent symptom in both groups. Proteinuria and anemia were prevalent in the early-onset SLE group (46.4%, 82.1%). The majority of the early-onset SLE (78.2%) group were anti-dsDNA positive
compared to 42.5% in the late-onset SLE group. Similarly, 78.4% of the early-onset SLE group had hypocomplementemia compared to 44.7% in the late-onset SLE group. Renal insufficiency and thromboembolic events were more prevalent in the early-onset SLE group (24.2%, 13.6%), while pulmonary hypertension and hepatitis more prevalent in the late-onset SLE group (15% and 20%, respectively). Estimated 5-year survival
analysis was lower in the late-onset SLE group compared to the early-onset SLE group.
Conclusion: Early-onset SLE had a higher frequency of American College of Rheumatology criteria than the late-onset SLE group. However, the late-onset SLE group exhibited a higher frequency of medical comorbidities with a lower 5-year survival rate.
Keywords:
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).